23. Aug. 2026•1 Min. Lesezeit
MHRA Alerts Missing Safety Info for Tuzulby Prolonged‑Release Tablets
Neuraxpharm UK Ltd reported missing safety information in the Patient Information Leaflet and Summary of Product Characteristics for certain batches of Tuzulby prolonged‑release 20 mg, 30 mg and 40 mg tablets.